Background illustration for clinical trials search

Bristol Myers Squibb Clinical Trials

Find clinical trials for Bristol Myers Squibb. Search for Bristol Myers Squibb clinical trials in different cities and states across the United States.

Filter

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

for
Schizophrenia, Autism-Related Irritability
Location: Boston MA, Orlando FL, Lawrenceville GA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 5 - 17

Code: NCT07424404

Phase 3, Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Westbury NY, New York NY, Lancaster PA, York PA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361510

Phase 3, Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

for
Hepatocellular Carcinoma (HCC)
Location: Hackensack NJ, Nashville TN, Portland OR, Duarte CA
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07291076

Phase 1, Phase 2, Recruiting

A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants

for
Healthy Volunteers
Location: Miami FL
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 60

Code: NCT07226817

Phase 1, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

for
Advanced Renal Cell Carcinoma (RCC)
Location: New York NY, Baltimore MD, Washington D.C. DC,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07293351

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

for
Relapsed/Refractory Small Cell Lung Cancer
Location: Durham NC, Buffalo NY, Cleveland OH, Detroit MI,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07325136

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

for
Schizophrenia
Location: Boston MA, Orlando FL, Lawrenceville GA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 13 - 17

Code: NCT07288567

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Lake Success NY, New York NY, Chapel Hill NC, Salem VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221149

Phase 2, Phase 3, Recruiting

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Boston MA, New York NY, Durham NC, Sarasota FL,
Sponsor: Bristol-Myers Squibb

Sex: Male

Age: 18+

Code: NCT06067841

Phase 1, Recruiting

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

for
Urothelial Cancer
Location: New York NY, Montreal, Baltimore MD, Ottawa,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07106762

Phase 2, Phase 3, Recruiting

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

for
Alzheimer Disease, Agitation
Location: Newton MA, Morehead City NC, Virginia Gardens FL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT06937229

Phase 3, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

for
Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC),
Location: Baltimore MD, Fairfax VA, Toronto, San Antonio TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07223047

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Shirley NY, Sherbrooke, Mineola NY, Lake Success NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221357

Phase 2, Phase 3, Recruiting

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

for
Renal Cell Carcinoma
Location: Boston MA, New York NY, Philadelphia PA, Nashville TN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07195682

Phase 1, Recruiting

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.

for
Healthy Volunteers
Location: Anaheim CA
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 70+

Code: NCT07283263

Phase 1, Recruiting

Mavacamten Pregnancy Surveillance Program

for
Breastfeeding, Hypertrophic Cardiomyopathy, Pregnancy Related
Location: Wilmington NC
Sponsor: Bristol-Myers Squibb

Sex: Female

Age: 15+

Code: NCT05939700

Recruiting

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

for
Systemic Lupus Erythematosus (SLE)
Location: Calgary, West Long Branch NJ, Brooklyn NY, Ottawa,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 16+

Code: NCT07175285

Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

for
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukaemia,
Location: Dallas TX, Salt Lake City UT
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 0+

Code: NCT06357754

Recruiting

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

for
Non-Small Cell Lung Cancer
Location: Boston MA, Mineola NY, New York NY, Philadelphia PA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07100080

Phase 2, Phase 3, Recruiting

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

for
Solid Tumours
Location: Pittsburgh PA, Sioux Falls SD, Fort Worth TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07160725

Phase 1, Phase 2, Recruiting